AI assistant
Sending…
Passage BIO, Inc. — Director's Dealing 2021
May 22, 2021
34849_dirs_2021-05-21_0e81f819-fd78-422b-8082-f98a3157972e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Passage BIO, Inc. (PASG)
CIK: 0001787297
Period of Report: 2021-05-21
Reporting Person: Morris Richard Steven (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-21 | Common Stock | P | 2171 | $13.8183 | Acquired | 5454 | Direct |
Footnotes
F1: Includes 2020 Employee Stock Purchase Plan allocations of 1,495 shares that occurred since the date of the reporting person's last ownership report.
More from Passage BIO, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 20
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Director's Dealing
2026
Mar 18
Annual Report
2026
Mar 3
Regulatory Filings
2026
Mar 3
Director's Dealing
2026
Jan 12
Director's Dealing
2026
Jan 12